Sanofi Today
Our Science
We chase the miracles of science to improve people’s lives. But we can’t do it alone. We work closely with healthcare professionals, patient advocates, governments and industry so we can have the biggest impact.
Trending
November 29, 2023
Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology
Targeted protein degradation is an investigational new treatment approach that may have major implications in the immunology and inflammation space.
October 10, 2023
Tackling atopic dermatitis from all angles
July 27, 2023
Partner Spotlight: miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases
In case you missed it
June 12, 2023
Sanofi x Viva Tech 2023: Artificial Intelligence, Real-Life Impact
May 16, 2023
Rethinking the science of COPD
May 17, 2023
Building a More Equitable Future through Inclusive Clinical Trials
Spotlight Messenger RNA
June 12, 2022
Sanofi x Viva Tech 2023: Artificial Intelligence, Real-Life Impact
November 1, 2021
mRNA technology platform
March 7, 2023
Adjusting to Life with Multiple Myeloma: Bernard’s Story
Everything About Our Science
Year
November 29, 2023
Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology
October 10, 2023
Tackling atopic dermatitis from all angles
July 27, 2023
Partner Spotlight: miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases
July 25, 2023
Harnessing the potential of mRNA to overcome major healthcare challenges
June 28, 2023
mRNA Technology: Vaccines and Beyond
June 22, 2023
Following the Science to Improve Care in Rare Blood Disorders
June 21, 2023
From Aspirations to Reality: My Journey as a Woman Scientist to Redefine Hemophilia Therapies
June 19, 2023
AI Goes Industrial
June 19, 2023